Literature DB >> 28695974

What determines the quality of life of adult patients after Fontan procedure?

Monika Smaś-Suska1, Natalia Dłużniewska, Piotr Weryński, Jacek Pająk, Wojciech Płazak, Maria Olszowska, Piotr Podolec, Lidia Tomkiewicz-Pająk.   

Abstract

BACKGROUND: Despite the low early mortality of Fontan procedures, Fontan patients are prone to vari-ous cardiac and extra-cardiac complications in the long term. This may influence patient perception of their health and outcome. The aim of the study was to assess the relationship of multi-organ compli-cations and physical efficiency with self-reported health-related quality of life (QOL) in adult Fontan patients.
METHODS: Quality of life was assessed with the Short Form-36 questionnaire. Laboratory tests were done together with echocardiography, plethysmography, and cardiopulmonary exercise test.
RESULTS: The QOL was poorer in patients than in control subjects. The physical characteristics of patients correlated with dynamic ventilatory parameters, heart rate at the peak of exercise, alanine aminotransferase and albumin level.
CONCLUSIONS: Liver impairment and chronotropic incompetence during exercise are associated with poor QOL in patients after Fontan procedure. In these patient, hepatic, pulmonary and cardiac functions should be carefully monitored. (Cardiol J 2018; 25, 1: 72-80).

Entities:  

Keywords:  SF-36; adult Fontan patients; exercise tolerance; multiorgan complications; pulmonary function test; quality of life

Mesh:

Year:  2017        PMID: 28695974     DOI: 10.5603/CJ.a2017.0078

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  3 in total

1.  Quality of life in adults with repaired tetralogy of Fallot.

Authors:  Natalia Dłużniewska; Piotr Podolec; Maria Olszowska; Piotr Weryński; Bogdan Suder; Grzegorz Kopeć; Lidia Tomkiewicz-Pająk
Journal:  Kardiochir Torakochirurgia Pol       Date:  2018-06-25

2.  Health-Related Quality of Life in Children, Adolescents, and Adults With a Fontan Circulation: A Meta-Analysis.

Authors:  Kate H Marshall; Yves D'Udekem; Gary F Sholler; Alexander R Opotowsky; Daniel S J Costa; Louise Sharpe; David S Celermajer; David S Winlaw; Jane W Newburger; Nadine A Kasparian
Journal:  J Am Heart Assoc       Date:  2020-03-16       Impact factor: 5.501

Review 3.  State of the art of the Fontan strategy for treatment of univentricular heart disease.

Authors:  Jelle P G van der Ven; Eva van den Bosch; Ad J C C Bogers; Willem A Helbing
Journal:  F1000Res       Date:  2018-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.